G Square Capital is a London-based private equity firm that specializes in investing in healthcare companies across Europe. The company, which focuses primarily on mid-market buy-out and expansion capital transactions, has established itself as a key player in the venture capital and private equity principals space. G Square Capital's investment strategy targets all segments of the healthcare industry, with the exception of biotech.

Located at 28 Savile Row in London, England, the company's central location allows it to maintain a strong presence in the European market. Its diverse portfolio comprises a range of healthcare services platform companies spanning various European countries, including Spain, Switzerland, Germany, Finland, Norway, Sweden, Belgium, the Netherlands, France, and the United Kingdom.

One of the factors that set G Square Capital apart from its competitors is its commitment to investing in a wide array of healthcare sectors. By avoiding a narrow focus on biotech, the company can ensure that its investments are well-diversified, leading to a more stable and robust portfolio. This strategy has allowed G Square Capital to build strong partnerships with companies across Europe, helping to drive innovation and growth in the healthcare sector.

G Square Capital's website, http://gsquarecapital.com, offers further insight into the company's investment approach and portfolio. The site highlights the firm's dedication to creating value for its investors and portfolio companies alike, with a focus on long-term growth and sustainable success.

In summary, G Square Capital is a leading private equity firm that invests in healthcare companies across Europe. With a diverse portfolio and a commitment to long-term success, the company is well-positioned to continue making a significant impact on the European healthcare sector for years to come.